UpDown Stock Analysis Comments For 'What You Should Know About DNDN and Provenge' (DNDN) http://www.updown.com/What-You-Should-Know-About-DNDN-and-Provenge/stock-tip/26191 the UpDown - Beat the market. Earn money. Zero Risk. Fri, 19 Jun 2009 10:17:53 EDT Fri, 19 Jun 2009 10:17:53 EDT Stock Analysis Comments http://www.updown.com/What-You-Should-Know-About-DNDN-and-Provenge/stock-tip/26191/rss 1440 http://www.updown.com/images/updown/logo.jpg UpDown Stock Analysis Comments For 'What You Should Know About DNDN and Provenge' (DNDN) http://www.updown.com/What-You-Should-Know-About-DNDN-and-Provenge/stock-tip/26191 contact@updown.com (UpDown) RE: What You Should Know About DNDN and Provenge (DNDN) http://www.updown.com/What-You-Should-Know-About-DNDN-and-Provenge/stock-tip/26191 <div>By <a href=http://www.updown.com/member/Jerrubaal>Jerrubaal</a></div><div>With all respect (that is due) to the FDA's requirements. Many pharms meet & exceed their requirements only to be pulled after more testing. As for the claims that any "most recent trial results" could possibly "constitute conclusive proof" of anything at all, positive or negative, it seems you are either a) selling something or b) do not understand the concept of trials. Trials are conducted, by and large, by the companies manufacturing the drugs and are more often than not given on an 'ideal situation' prognosis. They have the medicine distributed by nurses to specific 'case studies' that are monitored and watched constantly. This doesn't mean the results are insignificant but it is far from 'conclusive proof' which in most medical opinions is not officially granted until many years after the drug (and generics) are released. I did like your description of how it works though, and if this drug did have a higher occurrence than a placebo (which is the real test- not drug vs Taxotere) then I certainly do hope it passes the FDA and is available to do some good in the near future for a reasonable price. Again though "with a proven concept for sure" - the concept that a drug produced that treats a condition will be profitable is not in the least proven. Many drugs treat the condition yet make no money at all for the pharms that spend millions researching. Again though, I do hope it works, but I think calling it a closed case is going too far at this point.</div> Stock Analysis Comments comment-18552 Fri, 19 Jun 2009 10:17:53 EDT UpDown Stock Analyses RE: What You Should Know About DNDN and Provenge (DNDN) http://www.updown.com/What-You-Should-Know-About-DNDN-and-Provenge/stock-tip/26191 <div>By <a href=http://www.updown.com/member/Crosh>Crosh</a></div><div>I'm sorry to hear that. I hope you didn't short too much or you're probably feeling the hurt right now :( And DNDN still has a ways to go. I'd wait until some people take some of their massive profits and the stock drops a bit and try to cover everything ASAP. Good luck.</div> Stock Analysis Comments comment-18519 Mon, 08 Jun 2009 09:24:36 EDT UpDown Stock Analyses RE: What You Should Know About DNDN and Provenge (DNDN) http://www.updown.com/What-You-Should-Know-About-DNDN-and-Provenge/stock-tip/26191 <div>By <a href=http://www.updown.com/member/Crosh>Crosh</a></div><div>I'm sorry to hear that. Really I am.</div> Stock Analysis Comments comment-18442 Mon, 11 May 2009 15:35:47 EDT UpDown Stock Analyses RE: What You Should Know About DNDN and Provenge (DNDN) http://www.updown.com/What-You-Should-Know-About-DNDN-and-Provenge/stock-tip/26191 <div>By <a href=http://www.updown.com/member/stockprofit>stockprofit</a></div><div>Do not imply this is a done deal. Nothing has been approved yet. Invest at your own risk. I shorted on this account and my real account. </div> Stock Analysis Comments comment-18419 Tue, 05 May 2009 22:12:44 EDT UpDown Stock Analyses